Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001735276-19-000119
Filing Date
2019-12-26
Accepted
2019-12-26 16:02:35
Documents
1
Period of Report
2019-12-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 4240
  Complete submission text file 0001735276-19-000119.txt   5748
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACORDA THERAPEUTICS 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address
Greene Barry E (Reporting) CIK: 0001291963 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36407 | Film No.: 191310598